-
Bharat Biotech’s Covaxin 65.2% effective against delta variant
The efficacy analysis demonstrates Covaxin to be 93.4% effective against severe symptomatic Covid-19 cases
-
India’s Covaxin effectively neutralises Delta variant of Covid, says NIH
Covaxin generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2.
-
AstraZeneca Covid vaccine produces stronger immune response with an 11-month gap: Study
With a 45-week dosing interval between the first and second dose, antibody levels were four times higher than with a 12-week interval.
